A bipartisan bill to require major food allergens and gluten to be identified in medications

A bipartisan bill (H.R.4263) to require allergen labeling in medications was introduced in the House by Representatives Dean Phillips (D-MN-3), Mikie Sherrill (D-NJ-11), Representative Michael Lawler (R-NY-17), Representative Mike Gallagher (R-WI-8) on June 21. This bill was also introduced in the Senate by Senator Richard Blumenthal (D-CT) (S.2079). Gluten Free Watchdog is proud to endorse this bill to amend the Federal Food, Drug, and Cosmetic Act to require the label of a drug intended for human use to identify each ingredient in such drug that is, or is derived directly or indirectly from, a major food allergen or a gluten-containing grain, and for other purposes.

Because this bill was introduced with bipartisan support in the House, we are hopeful that it gains traction. If you would like to reach out to your members of Congress asking them to support this bill, you can find your representatives at https://www.house.gov/representatives and your senators at https://www.senate.gov/senators/senators-contact.htm.

For more information, see https://www.wisbusiness.com/2023/u-s-rep-gallagher-introduces-bill-to-require-allergen-labeling-in-medication/ and https://www.congress.gov/bill/118th-congress/house-bill/4263?s=1&r=1.

Sample phone/email/letter scripts are available at https://www.glutenfreewatchdog.org/news/sample-scripts-for-contacting-members-of-congress-asking-them-to-support-the-adina-act-a-bill-requiring-drug-labels-to-disclose-ingredients-made-from-allergens-or-gluten/.